Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.430
-0.030 (-2.05%)
Nov 13, 2026, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Inovio Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $6.33. The average 1-year stock price forecast is 342.87% higher than the current stock price, while the lowest is $5.00 (+249.65%) and the highest is $8.00 (+459.44%).
Price Target: $6.33 (+342.87%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Inovio Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +249.65% | Nov 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 → $6 | Buy | Reiterates | $8 → $6 | +319.58% | Nov 11, 2026 |
| Jefferies | Jefferies | Buy Reiterates $3 → $8 | Buy | Reiterates | $3 → $8 | +459.44% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
n/a
from 65.34K
Decreased by -100.00%
Revenue Next Year
64.88M
EPS This Year
-0.73
from -1.82
EPS Next Year
-0.03
from -0.73
EPS and Forward PE are based on non-GAAP adjusted numbers.